603087.SS
603087.SS
CNE100003ZH1
GAN&LEE PHARMACEUTICALS CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.052.146.960 3.045.347.805
33.1%
Cost of Revenue 978.951.762 766.506.269
27.7%
Gross Profit 3.073.195.198 2.278.841.536
34.9%
2.279.562.857 1.968.011.713
15.8%
Operating Income 793.632.341 310.829.823
155.3%
Pretax Income 1.229.805.744 630.385.148
95.1%
Net Income Common Stockholders 1.143.583.603 614.663.847
86.1%
-- --
--
-- --
--
ende